FDA doesn't care about other regulator decisions. It's not a "shaming" exercise. The question is why didn't NWBO file with the FDA?? After all their major protocol manipulations, NWBO knows the FDA would reject it.
Also, the UK market is very small for very high cost oncology treatments. Gilead's CAR-T treatment too multiple years to get any NICE coverage and it is patust their charity that limits coverage to only ~100 patients. No oncology drug company can survive on just revenue from the UK market. NWBO already is providing the drug to any patient through compassionate care but is getting very little cash from it.
Market Data 
Markets 
AI
